The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT02411903
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Registry
-
NCT02411903
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02411903. Randomized; no masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2016-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
- Condition
- Cerebral Infarction
- Condition
- Clopidogrel,Poor Metabolism of (Disorder)
- Intervention (Drug)
- atorvastatin and clopidogrel
- Intervention (Drug)
- rosuvastatin and clopidogrel
- Lead sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
Record details
- Record id
cardio:ct-nct02411903- Content hash
034df9996540859ed245551e900534de0efcf9732f5e172a8012905065a0932c